Tapentadol is partly metabolized with the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with prescription drugs that enrich or repress the action/expression of one or more of such enzymes, and with substrates of those enzymes (due to Competitiveness with the enzyme); some enzyme mediators/substrates call for https://sachax923fwo6.wannawiki.com/user